共 50 条
Gender Differences in Medication Adherence Among Adolescent and Young Adult Kidney Transplant Recipients
被引:52
|作者:
Boucquemont, Julie
[1
]
Pai, Ahna L. H.
[2
,3
]
Dharnidharka, Vikas R.
[4
,5
]
Hebert, Diane
[6
]
Furth, Susan L.
[7
,8
]
Foster, Bethany J.
[9
,10
,11
]
机构:
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] Cincinnati Childrens Hosp Med Ctr, Ctr Adherence & Self Management, Cincinnati, OH 45229 USA
[3] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[4] Washington Univ, Sch Med, Div Pediat Nephrol Hypertens & Pheresis, St Louis, MO USA
[5] St Louis Childrens Hosp, St Louis, MO 63178 USA
[6] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada
[7] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[8] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[9] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada
[10] McGill Univ, Dept Pediat, Montreal, PQ, Canada
[11] Montreal Childrens Hosp, Div Nephrol, Dept Pediat, Montreal, PQ, Canada
基金:
美国国家卫生研究院;
关键词:
GRAFT FAILURE;
IMMUNOSUPPRESSANT ADHERENCE;
SEX-DIFFERENCES;
THERAPY;
RISK;
PHARMACOKINETICS;
NONADHERENCE;
REGIMEN;
BRAIN;
D O I:
10.1097/TP.0000000000002359
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Background. Among kidney transplant recipients, gender differences in medication adherence may contribute to higher graft failure risks observed in girls and young women compared with boys and young men. Our aim was to determine whether adherence differs by gender, and whether gender differences vary by age in adolescent and young adult kidney transplant recipients. Methods. We examined data from the 3-month run-in period (no intervention) of the randomized Teen Adherence in Kidney transplant Effectiveness of Intervention trial. Adherence was monitored using electronic pillboxes in 136 patients (11-24 y) followed in 8 transplant centers in Canada and the United States. We used ordinal logistic regression with generalized estimating equations to estimate the association between gender and each of daily taking (proportion of prescribed doses taken) and timing (proportion of prescribed doses taken on time) adherence, considering effect modification by age (11-16 y vs 17-24 y). Results. No difference in taking adherence was observed by gender among participants aged 11 to 16 years (odds ratio [OR], 0.92; 95% confidence interval [CI], 0.55-1.54), whereas among participants aged 17 to 24 years, women had significantly greater odds of higher taking adherence scores (OR, 3.03; 95% CI, 1.20-7.66) than men. Results were similar for timing adherence, with no difference among participants aged 11 to 16 years (OR, 1.03; 95% CI, 0.65-1.63) but a greater odds of higher timing adherence scores in women than in men among participants aged 17 to 24 years (OR, 3.26; 95% CI, 1.43-7.45). There were no differences in adherence assessed by self-report or SD of tacrolimus trough levels. Conclusions. Gender differences in adherence vary by age. Whereas younger adolescents show no adherence differences by gender, young women show much better adherence than young men.
引用
收藏
页码:798 / 806
页数:9
相关论文